Evidence map›Paper›PMID 36034504›Full record

ArticleJournal of neurosurgery. Case lessons2021

A case of brain metastasis with pathological transformation of long-surviving malignant pleural mesothelioma: illustrative case.

Ryuichi Noda, Shunsuke Yanagisawa, Masato Inoue, Tetsuo Hara

Abstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Cerebral metastases of malignant mesothelioma.Journal of surgical case reports · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ryuichi NodaDepartment of Neurosurgery, Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Shunsuke YanagisawaDepartment of Neurosurgery, Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Masato InoueDepartment of Neurosurgery, Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Tetsuo HaraDepartment of Neurosurgery, Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalignant pleural mesothelioma (MPM) is a rare cancer, and in 80% of cases the cause is asbestos exposure. In 1972, the World Health Organization (WHO) declared asbestos is a carcinogenic substance. Since then, every developed country has restricted and banned the product. Because of its high heat resistance, asbestos had been widely used as building material for decades. The WHO estimated that approximately 125 million people are exposed to asbestos, and more than 107,000 die from asbestos-related diseases annually. Because of its long incubation period, the number of patients is estimated to keep increasing in the near future. OBSERVATIONS: The authors report a case of long-surviving MPM with a rushed clinical course after brain metastasis. A 69-year-old woman diagnosed with MPM (epithelial type) 6 years earlier presented with a brain metastasis. The pathological result of the brain metastasis was the sarcomatoid type. This case showed the possibility of subtype transition after long survival. LESSONS: This article aids in understanding the long-term natural history of MPM and the possibility of epithelial-mesenchymal transition. Neurosurgeons have to be aware of its the natural history and the possibility of brain metastasis.

Indexed as

asbestosbrain metastasisEMT = epithelial-mesenchymal transitionepithelial-mesenchymal transitionIMRT = intensity-modulated radiation therapymalignant pleural mesotheliomaMPM = malignant pleural mesotheliomaMRI = magnetic resonance imagingPEM = pemetrexedWHO = World Health Organization

Identifiers

PMID36034504
PMCPMC9394164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.